Sprim Als Investments

Sprim Als has invested in 7 companies and its latest investment was Prota on Jan 15, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Prota is an Australia-based biotechnology company that discovers and develops novel oral immunotherapies for the treatment of food allergies.
$21M
Jan 15, 2024
-
RegASK is a Singapore-based AI platform that provides solutions such as regulatory intelligence and analytics for businesses.
$10M
Dec 14, 2022
-
AUM is an oncology-focused biotechnology company that develops medicines for the treatment of cancer.
$27M
Oct 11, 2021
-
OBVIOHEALTH is a provider of mobile-based clinical trail services.
$31M
Jun 30, 2021
-
vWise develops an employee benefits platform that offers retirement plan enrollment and analytics solutions for advisors.
$8.6M
Jun 06, 2021
-

Frequently Asked Questions about Sprim Als

  1. What is Sprim Als investing in?

    Sprim Als has invested in 7 companies including Prota, RegASK and AUM Biosciences
  2. What company did Sprim Als invest in?

    Sprim Als invested in a total 7 companies including Prota, RegASK and AUM Biosciences
  1. What are the top 5 investments by Sprim Als?

    The top companies in which Sprim Als invested are Prota, RegASK, AUM Biosciences, ObvioHealth and Vwise, Inc.